The interventional treatment of aortic stenosis is currently based on transcatheter aortic
valve implantation/replacement (TAVI/TAVR) and surgical aortic valve replacement (SAVR) …

Although initially conceived for high-risk patients who are ineligible for surgical aortic valve
replacement (SAVR), transcatheter aortic valve replacement (TAVR) is now recommended …

With the expansion of the indications of transcatheter aortic valve replacement (TAVR), it is
being increasingly performed in older patients with aortic stenosis to improve their quality of …

Background: Prosthetic valve endocarditis (PVE) is a rare but critical mechanism of valve
failure and death after transcatheter and surgical aortic valve replacement (TAVR, SAVR) …

Aims: Transcatheter aortic valve implantation (TAVI) has recently developed into an
accepted alternative to conventional surgery in high-risk patients. According to current data …

Background and aims Prosthetic valve endocarditis (PVE) is the prognostically most
unfavourable complication after aortic valve replacement. This study aims to contribute to a …

Heart valve replacement is the most common cardiac surgical operation performed
worldwide for infective endocarditis (IE). Long-term durability and avoidance of infection …

Transcatheter aortic valve replacement (TAVR) is a paradigm shift for the management of
severe symptomatic aortic stenosis. Infective endocarditis is a dreaded complication, which …

Transcatheter aortic valve replacement (TAVR) can improve the symptoms and prognosis of
patients with severe aortic stenosis who, due to a high expected operative risk, would not …

Purpose Most data regarding infective endocarditis (IE) after transcatheter aortic valve
implantation (TAVI) comes from TAVI registries, rather than IE dedicated cohorts. The …